🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. Basiliximab,

    The First People's Hospital of Lianyungang

    Beta-Thalassemia Major

    approved small molecule completed

    1 trial

  2. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved small molecule active

    1 trial

  3. Bempedoic Acid / Ezetimibe Oral Tablet

    Esperion Therapeutics

    Cardiovascular Diseases

    approved small molecule active

    1 trial

  4. Bempedoic Acid 180 MG Oral Tablet

    Esperion Therapeutics

    Healthy Lactating Women

    approved small molecule completed

    1 trial

  5. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  6. Berotralstat, Berotralstat, Berotralstat, BEROTRALSTAT, Berotralstat

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema

    approved small molecule active

    1 trial

  7. Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral

    The George Institute

    Respiratory diseases

    approved small molecule active

    1 trial

  8. Bevacizumab

    Arrowhead Pharmaceuticals Ireland Limited

    Pterygium

    approved small molecule completed

    1 trial

  9. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial

  10. Biomarker

    United Therapeutics Europe Ltd

    Transplantation, Liver

    approved gene therapy terminated

    1 trial

  11. Blinatumomab

    The First People's Hospital of Lianyungang

    Acute B-cell Lymphoblastic Leukemia

    approved small molecule active

    1 trial

  12. Brand lamotrigine

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    approved small molecule completed

    1 trial

  13. Brodalumab 70 mg, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP, without the active substance., Kyntheum 210 mg solution for injection in pre-filled syringe

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial

  14. Brolucizumab

    The University of Hong Kong

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial

  15. Bupivacaine FNB

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    1 trial

  16. Bupivacaine SNB

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    1 trial

  17. Bupivacaine liposome injectable suspension (IPSA block)

    Pacira Ireland Limited

    Total Knee Arthroplasty

    approved small molecule active

    1 trial

  18. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    approved small molecule completed

    28 trials

  19. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  20. Bupropion Extended Release Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Postpartum Smoking Relapse

    approved small molecule active

    1 trial

  21. Busulfan

    The First People's Hospital of Lianyungang

    Thalassemia Major

    approved small molecule completed

    1 trial

  22. CAPECITABINE, CALCIUM FOLINATE, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Calciumfolinat Kabi 10 mg/ml Injektions-/Infusionslösung, FLUOROURACIL, Lenvatinib, Lenvatinib, Calciumfolinat-GRY® 100 mg/10 ml Injektionslösung, OXALIPLATIN, Lenvatinib, CALCIUM LEVOFOLINATE , CAPECITABINE

    Merck Sharp and Dohme

    Advanced/Metastatic Gastroesophageal Adenocarcinoma

    approved small molecule active

    1 trial

  23. CARBOPLATIN, PACLITAXEL, DOCETAXEL, VINORELBINE TARTRATE, CISPLATIN, PEMETREXED

    CERO THERAPEUTICS HOLDINGS, INC.

    Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)

    approved small molecule active

    1 trial

  24. CARDIOPLEGIA SOLUTIONS

    The George Institute

    Cardiovascular pathology

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources